Skip to content

Clinical trials

Major Depressive Disorder trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Country / region: South Korea Clear all

66 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20073
20085
20094
20104
20117
20123
20132
20141
20153
20166
20172
20192
20203
20213
20228
20232
20241
20251
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed43
Unknown status10
Recruiting5
Terminated5
Withdrawn1
Enrolling by invitation1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
H. Lundbeck A/S6
Eli Lilly and Company5
Janssen Research & Development, LLC5
Samsung Medical Center5
Ewha Womans University3
Pfizer3
Seoul National University Hospital3
Takeda3
Korea University2
Korea University Anam Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder66
Depressive Disorder8
Mood Disorders8
Bipolar Disorder4
Anxiety Disorders2
Mental Disorders2
Alcoholism1
Alzheimer Disease1
Anhedonia1
Cognitive Dysfunction1

Trials

Showing 1 to 25 of 66. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.